Location History:
- Boston, MA (US) (2017)
- Cambridge, MA (US) (2022)
Company Filing History:
2 out of 303 
1 out of 1,209 
1 out of 3,539 
Years Active: 2017-2022
Title: Michael Pacold: Innovator in Biomedical Research
Introduction
Michael Pacold is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic compounds. With a total of 2 patents, his work focuses on addressing critical health challenges.
Latest Patents
Michael Pacold's latest patents include innovative compounds aimed at inhibiting phosphoglycerate dehydrogenase (PHGDH) and promoting intestinal stem cell function. The first patent provides compounds of Formula (II) and their various forms, which are designed to treat diseases associated with the over-expression of PHGDH, such as various cancers and inflammatory diseases. The second patent discloses methods and compositions that stimulate the proliferation and self-renewal of intestinal stem cells, particularly useful in minimizing cellular damage from radiation exposure.
Career Highlights
Throughout his career, Michael has worked with esteemed institutions such as the Whitehead Institute for Biomedical Research and Dana-Farber Cancer Institute. His research has been pivotal in advancing our understanding of cancer biology and regenerative medicine.
Collaborations
Michael has collaborated with notable scientists, including David Sabatini and Pekka Katajisto, contributing to a rich exchange of ideas and innovations in the field.
Conclusion
Michael Pacold's work exemplifies the impact of innovative research in addressing complex health issues. His patents and collaborations continue to pave the way for advancements in biomedical therapies.